MYT NETHERLANDS PARENT BV (MYTE)
US55406W1036 - ADR
MYTE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. The financial health of MYTE is average, but there are quite some concerns on its profitability. MYTE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MYTE reported negative net income in multiple years.
In multiple years MYTE reported negative operating cash flow during the last 5 years.
1.2 Ratios
MYTE has a worse Return On Assets (-3.90%) than 65.08% of its industry peers.
MYTE's Return On Equity of -6.36% is in line compared to the rest of the industry. MYTE outperforms 47.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.9% | ||
| ROE | -6.36% | ||
| ROIC | N/A |
ROA(3y)-3.24%
ROA(5y)-1.51%
ROE(3y)-4.55%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 47.40%, MYTE is doing good in the industry, outperforming 75.40% of the companies in the same industry.
MYTE's Gross Margin has been stable in the last couple of years.
MYTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 47.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.09%
2. Health
2.1 Basic Checks
MYTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYTE has been increased compared to 1 year ago.
MYTE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MYTE is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.00 indicates that MYTE is not in any danger for bankruptcy at the moment.
MYTE has a Altman-Z score of 3.00. This is in the better half of the industry: MYTE outperforms 66.67% of its industry peers.
MYTE has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
MYTE has a better Debt to Equity ratio (0.11) than 69.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3 |
ROIC/WACCN/A
WACC6.75%
2.3 Liquidity
MYTE has a Current Ratio of 2.02. This indicates that MYTE is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.02, MYTE is doing good in the industry, outperforming 78.57% of the companies in the same industry.
A Quick Ratio of 0.25 indicates that MYTE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.25, MYTE is doing worse than 82.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 0.25 |
3. Growth
3.1 Past
The earnings per share for MYTE have decreased strongly by -89.74% in the last year.
The Revenue has grown by 10.87% in the past year. This is quite good.
The Revenue has been growing by 20.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-89.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-66.67%
Revenue 1Y (TTM)10.87%
Revenue growth 3Y19.58%
Revenue growth 5Y20.42%
Revenue growth Q2Q3.64%
3.2 Future
MYTE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.05% yearly.
The Revenue is expected to grow by 11.79% on average over the next years. This is quite good.
EPS Next Y-21.18%
EPS Next 2Y30.98%
EPS Next 3Y14.05%
EPS Next 5YN/A
Revenue Next Year10.27%
Revenue Next 2Y11.2%
Revenue Next 3Y11.79%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 98.00, the valuation of MYTE can be described as expensive.
MYTE's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 24.67. MYTE is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 9.69, the valuation of MYTE can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYTE indicates a rather cheap valuation: MYTE is cheaper than 80.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.02, MYTE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 98 | ||
| Fwd PE | 9.69 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MYTE's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.98%
EPS Next 3Y14.05%
5. Dividend
5.1 Amount
MYTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MYT NETHERLANDS PARENT BV
NYSE:MYTE (4/30/2024, 6:15:23 PM)
3.92
-0.39 (-9.05%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap332.77M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 98 | ||
| Fwd PE | 9.69 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.9% | ||
| ROE | -6.36% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 47.4% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.02 | ||
| Quick Ratio | 0.25 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-89.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-21.18%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.87%
Revenue growth 3Y19.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y